Enrique Smith

Learn More
BACKGROUND The relationship between pneumococcal conjugate vaccine-induced antibody responses and protection against community-acquired pneumonia (CAP) and acute otitis media (AOM) is unclear. This study assessed the impact of the ten-valent pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on these end points. The primary(More)
There is information missing from the Competing Interests statement. While the authors have already declared in the Funding statement that GlaxoSmithKline (GSK) Biologicals SA was the funding source and was involved in all stages of the study conduct and analysis, they did not disclose all potential financial competing interests for each individual(More)
  • 1